OxyContin bottle on counter. Photo: PureRadiancePhoto/Shutterstock.com 'Deadly Roadmap': McKinsey Enters $573M Settlement Over Opioids Profits
Forty-seven states reached the settlement with global consulting firm McKinsey & Co. over its work on behalf of opioid makers.
February 04, 2021 at 01:16 PM
3 minute read
A coalition of 47 states, the District of Columbia and five U.S. territories Thursday announced they've reached a $573 million settlement agreement with global consulting firm McKinsey & Co. over its role in advising opioid companies on how to promote and profit from their products.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Law Firms Mentioned
Trending Stories
- 1First Lawsuit Filed Alleging Contraceptive Depo-Provera Caused Brain Tumor
- 2BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 3The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 4The Growing Tension—And Opportunity—in Big Law Nonequity Tiers
- 5The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
